drugset / Trial / NCT00560586

Nasal Budesonide in Children With Rhinitis and/or Mild Obstructive Sleep Apnea Syndrome

NCT00560586

Phase 4 Completed 62 enrolled University of Louisville
RandomizedCrossoverQuadruple-blindTreatment

Summary

-Intranasal budesonide therapy may lead to improved symptoms and sleep study findings in children with mild obstructive sleep apnea with and without allergic rhinitis that would not be treated with T\&A. The aim of the study is to conduct a randomized double blind cross-over trial comparing the effect of once a day intranasal budesonide therapy vs. placebo in children with mild sleep apnea that would not be candidates for T\&A.

Timeline

Start
2004-04
Primary completion
2006-05
Completion
2007-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Budesonide Small molecule 64 ug Intranasal